Education
About Us
Working with TipRanks
Follow Us
Daniel Alexander Yerace Insider Profile
4 Followers
Daniel Alexander Yerace, VP Operations, Director at Coeptis Therapeutics Holdings, holds 70.53K shares in Coeptis Therapeutics Holdings (Ticker: COEP).
Daniel Alexander Yerace has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Alexander Yerace's holdings
Insider Roles
VP Operations, Director
Roles that Daniel Alexander Yerace holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Alexander Yerace
Daniel Alexander Yerace's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Alexander Yerace's performance on stock
You May Also Like
Daniel Alexander Yerace insider profile FAQ
What is the percentage of profitable transactions made by Daniel Alexander Yerace?
The percentage of profitable transactions made by Daniel Alexander Yerace is ―.
What is the average return per transaction made by Daniel Alexander Yerace?
The average return per transaction made by Daniel Alexander Yerace is ―.
What stocks does Daniel Alexander Yerace hold?
Daniel Alexander Yerace holds: COEP stocks.
What was Daniel Alexander Yerace’s latest transaction?
Daniel Alexander Yerace latest transaction was an Uninformative Buy of $312.30K.
What was Daniel Alexander Yerace's most profitable transaction?
Daniel Alexander Yerace’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Alexander Yerace's role in Coeptis Therapeutics Holdings?
Daniel Alexander Yerace's role in Coeptis Therapeutics Holdings is VP Operations, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.